Anti-PD-1 Combo Boosts HER2+ Gastric Cancer Outcomes
A recent breakthrough in the treatment of HER2-positive alpha-fetoprotein-producing gastric cancer (AFPGC) offers a new beacon of hope for patients ...
A recent breakthrough in the treatment of HER2-positive alpha-fetoprotein-producing gastric cancer (AFPGC) offers a new beacon of hope for patients ...
Triple-negative breast cancer (TNBC) is notorious for its aggressive nature and resistance to conventional therapies, creating an urgent need for ...
In a groundbreaking development that has captured the attention of the oncology community, recent findings from the NRG-BN001 trial’s proton ...
In the relentless quest to combat acute myeloid leukemia (AML), a devastating blood cancer affecting roughly 20,000 Americans annually, researchers ...
A groundbreaking advancement in the treatment of thoracic cancers has emerged from researchers at the Fox Chase Cancer Center, heralding ...
A groundbreaking study from Johns Hopkins All Children’s Hospital unveils a novel strategy to harness the natural immune system in ...
In a groundbreaking study, scientists have turned their attention to the molecular intricacies of head and neck squamous cell carcinoma ...
In an unprecedented convergence of synthetic biology and cancer immunotherapy, scientists from the Yong Loo Lin School of Medicine at ...
Indiana University School of Medicine researchers have made a significant breakthrough in the battle against pancreatic cancer, a disease notorious ...
A groundbreaking advancement in cancer immunotherapy has emerged from researchers at the University of Basel and University Hospital Basel in ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine